bioRxivBiochemistryPreprint
VDAC2 stabilizes a membrane-inserted, primed intermediate of BAX activation
Varun RavishankariD, Laidy M. Alvero-GonzáleziD, Agathe Hubert, Zaiwei Zhang, Chloé Markarian, Valérie Prima, Sirine Chergui, Roberto MeleroiD, Florian StengeliD, Stéphen ManoniD, Jean‐Pierre DuneauiD, María Queralt-MartíniD, Lucie A. BergdolliD
Abstract
BAX, a major effector of mitochondrial apoptosis, is activated through a series of conformational transitions that lead to mitochondrial outer membrane permeabilization. Genetic studies have established VDAC2 as an essential regulator of BAX-mediated apoptosis, yet the molecular basis of this regulation remains unresolved. The absence of direct structural and biochemical characterization of VDAC2-BAX interactions has prevented mechanistic understanding of how VDAC2 influences BAX activation. Here, using complementary biochemical, biophysical and structural approaches, we reconstituted and characterized a stable VDAC2-BAX complex that was not observed with VDAC1, highlighting an isoform-specific role in BAX regulation. We show that VDAC2 captures and stabilizes a primed BAX conformation displaying the hallmarks of activation, including membrane insertion, BH3 exposure, and increased accessibility of the N-terminal activation region. By integrating AlphaFold3 predictions with molecular dynamics simulations, biochemical, biophysical and structural constraints, we derive an experimentally-supported structural model in which BAX is anchored through its 9 helix while its soluble domain partially extends over the VDAC2 pore. Together, our findings support a model in which VDAC2 facilitates BAX membrane insertion and stabilizes a membrane-inserted, activation- competent BAX intermediate. Rather than serving as a structural component of apoptotic pores, VDAC2 acts as a regulatory checkpoint in BAX activation. These results provide a molecular explanation for the emerging role of VDAC2 in mitochondrial apoptosis and establish structural basis for a previously inaccessible intermediate in the BAX activation pathway.
- organism: human
- assay: structural biology
- research focus: cell signaling & trafficking
- approach: biophysical modeling
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- BAX requires VDAC2 to mediate apoptosis and to limit tumor development
Hui San Chin, Mark F. van Delft, … Grant Dewson·bioRxiv·Feb 16, 2018
- Differential regulation of BAX and BAK apoptotic activity revealed by a novel small molecule
Kaiming Li, Yu Q. Yap, … Guillaume Lessène·Science AdvancesPeer-reviewed·Mar 5, 2025
- Molecular definition of the BAK:VDAC2 interaction as a target to manipulate apoptosis
Z. Yuan, M. F. van Delft, … G. Dewson·bioRxiv·Dec 13, 2023
- Structural basis of apoptosis induction by the mitochondrial voltage dependent anion channel
Melina Daniilidis, Umut Günsel, … Franz Hagn·Nature CommunicationsPeer-reviewed·Oct 27, 2025
- The membrane insertion of the pro-apoptotic protein Bax is a Tom22-dependent multi-step process: a study in nanodiscs
A. Rouchidane Eyitayo, L. Daury, … S. Manon·bioRxiv·Feb 16, 2024
- Molecular and topological reorganizations in mitochondrial architecture interplay during Bax-mediated steps of apoptosis
N. R. Ader, P. C. Hoffmann, … W. Kukulski·bioRxiv·Aug 1, 2018